These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24740103)
1. Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis. Chen X; Yang G; Zhang D; Zhang W; Zou H; Zhao H; Zhang X; Zhao S PLoS One; 2014; 9(4):e95139. PubMed ID: 24740103 [TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma. Tao Y; Liang G Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773 [TBL] [Abstract][Full Text] [Related]
3. Association between EGF +61 G/A and glioma risk in a Chinese population. Wang S; Zhao Y; Ruan Z; Chen H; Fan W; Chen J; Wu Q; Qian J; Zhang T; Huang Y; Lu D BMC Cancer; 2010 May; 10():221. PubMed ID: 20487573 [TBL] [Abstract][Full Text] [Related]
4. Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma. Hu M; Shi H; Xu Z; Liu W Tumour Biol; 2013 Jun; 34(3):1879-85. PubMed ID: 23645212 [TBL] [Abstract][Full Text] [Related]
5. A functional +61G/A polymorphism in epidermal growth factor is associated with glioma risk among Asians. Xu X; Xi L; Zeng J; Yao Q PLoS One; 2012; 7(7):e41470. PubMed ID: 22829952 [TBL] [Abstract][Full Text] [Related]
6. Association between +61G polymorphism of the EGF gene and glioma risk in different ethnicities: a meta-analysis. Tan D; Xu J; Li Y; Lai R Tohoku J Exp Med; 2010 Dec; 222(4):229-35. PubMed ID: 21123997 [TBL] [Abstract][Full Text] [Related]
7. A functional polymorphism in the epidermal growth factor gene is associated with risk for glioma in a Chinese population. Li Y; Zhao Y; Liu J; Liu P; Xu Y Genet Test Mol Biomarkers; 2012 May; 16(5):449-52. PubMed ID: 22106858 [TBL] [Abstract][Full Text] [Related]
8. Association between functional EGF+61 polymorphism and glioma risk. Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192 [TBL] [Abstract][Full Text] [Related]
9. Association between epidermal growth factor +61 G/A polymorphism and glioma risk in a Chinese Han population. Bao G; Wang M; Guo S; Han Y; Xu G J Int Med Res; 2010; 38(5):1645-52. PubMed ID: 21309478 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients. Muthusamy KA; Lian LH; Vairavan N; Chua KH; Waran V Genet Mol Res; 2012 Aug; 11(3):2939-45. PubMed ID: 22782629 [TBL] [Abstract][Full Text] [Related]
11. No association between EGF +61 A/G polymorphism and increased risk of glioma. Liu X; Li L; Chen X; Wang X; Mu L; Li Y; Xu Q; Xie Q; Lu F Int J Biol Markers; 2009; 24(2):77-82. PubMed ID: 19634110 [TBL] [Abstract][Full Text] [Related]
12. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy. da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252 [TBL] [Abstract][Full Text] [Related]
13. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression. Li YL; Tian Z; Zhao L; Zhang CL Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191 [TBL] [Abstract][Full Text] [Related]
14. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis. Zhang H; Liu H; Knauss JL Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607 [TBL] [Abstract][Full Text] [Related]
15. Association between GSTP1 Ile105Val polymorphism and glioma risk: a systematic review and meta-analysis. Xie P; Liang Y; Liang G; Liu B Tumour Biol; 2014 Jan; 35(1):493-9. PubMed ID: 23975366 [TBL] [Abstract][Full Text] [Related]
16. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population. Laus AC; de Paula FE; de Lima MA; Carlos CD; Gomes INF; de Marchi P; Valente JKN; Pioltini ABM; Miziara JE; da Silva CM; Viana LS; Scapulatempo-Neto C; Reis RM Mol Biol Rep; 2019 Apr; 46(2):2417-2425. PubMed ID: 30783937 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis. Zhong JH; You XM; Gong WF; Ma L; Zhang Y; Mo QG; Wu LC; Xiao J; Li LQ PLoS One; 2012; 7(3):e32159. PubMed ID: 22403631 [TBL] [Abstract][Full Text] [Related]
18. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis. Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233 [TBL] [Abstract][Full Text] [Related]
19. Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil. Pinto GR; Yoshioka FK; Clara CA; Santos MJ; Almeida JR; Burbano RR; Rey JA; Casartelli C Int J Biol Markers; 2009; 24(4):277-81. PubMed ID: 20108217 [TBL] [Abstract][Full Text] [Related]
20. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis. Sun S; Jin GJ; Zhao Y; Kang H Asian Pac J Cancer Prev; 2015; 16(7):3009-14. PubMed ID: 25854398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]